Biopharmaceutical Logistics Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032

Biopharmaceutical Logistics Market Size

Biopharmaceutical Logistics Market size is slated to depict robust growth from 2024-2032 driven by the surging adoption of temperature-regulated transportation of critical drugs and therapeutics. According to a EY-FICCI 2022 study, the number of cancer cases reported in India was estimated to reach 1.9 to 2 million in 2022. This growing cancer burden is likely to represent a lucrative demand for effective diagnostics and therapeutics, fueling the need for proper transportation and logistics.
 

The rapid deployment of various next-generation technologies is leading to the demand for production techniques associated with complex proteins, biologics, hormone medications, vaccines, and temperature-specific byproducts. Additionally, the upsurge in the incidences of metabolic disorders and cancers is accelerating the adoption of complex and more advanced therapeutics, further emphasizing the need for controlled environment during transportation.
 

The increased awareness of the importance of robust supply chains and the accelerated adoption of digital technologies for tracking and monitoring along with the heightened investments in cold chain infrastructure since the COVID-19 outbreak are positively impacting the demand for efficiency and resilience of biopharmaceutical logistics. However, stringent regulatory compliance, rising complex temperature-sensitive requirements, high operational costs, and challenges in maintaining uninterrupted supply chains, particularly during global crises may slow down the industry expansion.
 

Biopharmaceutical Logistics Market Trends

With the rise in complex, temperature-sensitive therapies and the urgency in global vaccine distribution, logistics providers are playing a pivotal role for ensuring the safe and timely transportation of sensitive pharmaceuticals. The demand for specialized cold chain logistics, advanced packaging solutions, and efficient last-mile delivery services is surging, driven by the imperative to maintain the integrity and efficacy of biopharmaceuticals.
 

The increasing focus on time-sensitive delivery also reflects the strong commitment to meeting healthcare demands promptly and safeguarding patient welfare, further propelling the industry expansion. For instance, in July 2023, AmerisourceBergen's World Courier, a specialist logistics provider, established a new transport station in the Greater Chicago region for expanding its capacity to provide storage and distribution options for products requiring temperature control and time-sensitive delivery.
 

Biopharmaceutical Logistics Market Analysis

The cold chain logistics segment is anticipated to experience a significant boost through 2032 due to the increasing production of temperature-controlled biologics and pharma products. The ease of compliance of temperature-sensitive products will foster the demand for cold chain services. Moreover, the rapid integration of telematics in the cold chain is allowing operators to strengthen the safety, connectivity, and efficiency of cargos.
 

Based on service, the warehouse and storage segment in the biopharmaceutical logistics market is projected to depict an exponential outlook through 2032 owing to the growing logistics requirements across the healthcare and pharmaceutical sectors. Newly trending services, such as third-party logistics are picking pace to help minimize overheads and OPEX. Furthermore, the increasing use of robots and barcode scanners for streamlined and more efficient supply chain management will complement the industry outlook.
 

Asia Pacific biopharmaceutical logistics market size is predicted to expand at a notable rate from 2024-2032 led by the solid footprint of pharma giants across the region. The massive population and the constantly growing geriatric patient pool in countries such as China, and India are fostering lucrative demand for medicines and therapeutics. To illustrate, in August 2023, UPS Healthcare expanded its UPS Premier service to India to meet the evolving demands of critical time- and temperature-sensitive healthcare shipments. The service also helped match the complex logistics requirements of pharmaceutical, medical devices, and laboratory testing to offer visibility, verification, and integrity of supported products and resources. The rising rate of generic and critical drug exports is another important trend for significant industry gains.
 

Biopharmaceutical Logistics Market Share

Leading biopharmaceutical logistics industry players are strategically investing in advanced technologies, enhancing cold chain capabilities, forming strategic alliances, and expanding global networks to strengthen their market share. To illustrate, DHL International GmbH stands out as a prominent market participant by providing a global network and advanced supply chain solutions for ensuring secure, efficient, and timely transportation of pharmaceuticals worldwide.
 

Some major companies in the biopharmaceutical logistics industry include-

• KUEHNE + NAGEL
• SF Express
• FedEx
• DHL International GmbH
• AmerisourceBergen Corporation
• United Parcel Service of America, Inc.
• Kerry Logistics Network Limited
• DB Schenker
• Agility

Biopharmaceutical Logistics Industry News

• In November 2023, UPS acquired MNX Globe Logistics, an international time-critical logistics company to strengthen its radio-pharma, temperature-controlled logistics, next-flight-out, and accelerated ground services for healthcare clients.